Abstract
Plasmid DNA is frequently used particularly for nonviral gene therapy. Conventional plasmid DNA contains bacterial backbone and resistance gene sequences, as well as immunogenic CpG motifs. These components are not required for transgene expression. They represent a potential risk for safe clinical application and reduce gene transfer rates as well as transgene expression. To overcome these drawbacks, the minicircle technology is removing such sequences, to improve performance and also to reduce DNA size. Here, we show the effective production of luciferase, GFP, or lacZ-carrying minicircle DNA with high yield and reproducible high quality. They are used for lipofection or electroporation gene transfer into human melanoma and colon carcinoma cell lines. Comparison of respective parental plasmid and minicircle-mediated luciferase gene transfer shows improved luciferase expression by minicircle in all cell lines. This is not associated with increase in intracellular minicircle copy numbers after lipofection or electroporation. The minicircles rather mediate enhanced transgene mRNA transcription compared to their parental plasmids. In addition, FACS analysis revealed increase in counts of GFP positive cells after minicircle gene transfer, indicating higher gene transfer rates. Furthermore, minicircle showed also improved performance in vivo after jet-injection gene transfer. Therefore, availability of minicircles with reproducible high quality and sufficient amount makes them an applicable and effective alternative to conventional plasmid gene vectors.
Similar content being viewed by others
References
Al-Dosari, M. S., & Gao, X. (2009). Nonviral gene delivery: Principle, limitations, and recent progress. The AAPS Journal, 11, 671–681.
Edelstein, M. L., Abedi, M. R., & Wixon, J. (2007). Gene therapy clinical trials worldwide to 2007—an update. The Journal of Gene Medicine, 9, 833–842.
Schleef, M., Blaesen, M., Schmeer, M., Marie, C., Scherman, D., & Dickson, G. (2010). Production of non viral DNA vectors. Current Gene Therapy, 10, 487–507.
Schleef, M., & Schmidt, T. (2001). Animal-free production of ccc-supercoiled plasmids for research and clinical applications. The Journal of Gene Medicine, 6, S45–S53.
Walther, W., & Stein, U. (2000). Viral vectors for gene transfer: A review of their use in the treatment of human disease. Drugs, 60, 249–271.
Pang, A. S. (1994). Production of antibodies against Bacillus thuringiensis delta endotoxin by injecting its plasmids. Biochemical and Biophysical Research Communications, 202, 1227–1234.
Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., & Varathalingam, A. (2008). CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nature Biotechnology, 26, 549–551.
Tolmachov, O. (2009). Designing plasmid vectors. Methods in Molecular Biology, 542, 117–129.
Valera, A., Perales, J. C., Hatzoglou, M., & Bosch, F. (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Human Gene Therapy, 5, 449–456.
Chen, Z. Y., He, C. Y., Meuse, L., & Kay, M. A. (2004). Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Therapy, 11, 856–864.
Riu, E., Grimm, D., Huang, Z., & Kay, M. A. (2005). Increase maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. Human Gene Therapy, 16, 558–570.
Darquet, A. M., Rangara, R., Kreiss, P., Schwartz, B., Naimi, S., Delaère, P., et al. (1999). Minicircle: An improved DNA molecule for in vitro and in vivo gene transfer. Gene Therapy, 6, 209–218.
Chen, Z. Y., He, C. Y., & Kay, M. A. (2005). Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Human Gene Therapy, 16, 126–131.
Kreiss, P., Cameron, B., Darquet, A. M., Scherman, D., & Crouzet, J. (1998). Production of a new DNA vehicle for gene transfer using site-specific recombination. Applied Microbiology and Biotechnology, 49, 560–567.
Mayrhofer, P., Schleef, M., & Jechlinger, W. (2009). Use of minicircle plasmids for gene therapy. Methods in Molecular Biology, 542, 87–104.
Sadowski, P. (1986). Site-specific recombinases: Changing partners and doing the twist. Journal of Bacteriology, 165, 341–347.
Gilbertson, L. (2003). Cre-lox recombination: Creative tools for plant biotechnology. Trends in Biotechnology, 21, 550–555.
Bigger, B. W., Tolmachov, O., Collomber, J. M., Fragkos, M., Palaszewski, I., & Coutelle, C. (2001). An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. Journal of Biological Chemistry, 276, 23018–23027.
Thorpe, H. M., & Smith, M. C. (1998). In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proceedings of the National Academy of Sciences of the United States of America, 95, 5505–5510.
Thorpe, H. M., Wilson, S. E., & Smith, M. C. (2000). Control of directionality in the site-specific recombination system of the Streptomyces phage phiC31. Molecular Microbiology, 38, 232–241.
Bigger B.W., Tolmachov O., Coutelle C. (2002). Methods for the production of minicircles. Imperial College Innovations. WO Patent 2002/083889.
Eberl, L., Kristensen, C. S., Givskov, M., Grohmann, E., Gerlitz, M., & Schwab, H. (1994). Analysis of the multimer resolution system encoded by the parCBA operon of broad-host-range plasmid RP4. Molecular Microbiology, 12, 131–141.
Smith, M. C., & Thorpe, H. M. (2002). Diversity in the serine recombinases. Molecular Microbiology, 44, 299–307.
Thomson, J. G., & Ow, D. W. (2006). Site specific recombination systems for the genetic manipulation of eukaryotic genomes. Genesis, 44, 465–476.
Jechlinger, W., Azimpour Tabrizi, T., Lubitz, W., & Mayrhofer, P. (2004). Minicircle DNA immobilized in bacterial ghosts: In vivo production of safe non-viral DNA delivery vehicles. Journal of Molecular Microbiology and Biotechnology, 8, 222–231.
Wooddell, C. I., Subbotin, V. M., Sebesty, M. G., Griffin, J. B., Zhang, G., Schleef, M., et al. (2011). Muscle damage following delivery of naked plasmid DNA into skeletal muscles is batch-dependent. Human Gene Therapy, 22, 225–235.
Kreiss, P., Mailhe, P., Sherman, D., & Pitard, B. (1999). Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Research, 27, 3792–3798.
Yin, W., Xiang, P., & Li, Q. (2005). Investigations of the effect of DNA size in transient transfection assay using dual luciferase system. Analytical Biochemistry, 346, 289–294.
Zhou, R., Geiger, R. C., & Dean, D. A. (2004). Intracellular trafficking of nucleic acids. Expert Opinion on Drug Delivery, 1, 127–140.
Khalil, I. A., Kogure, K., Akita, H., & Harashima, H. (2006). Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacological Reviews, 38, 32–45.
Chen, Z.-Y., He, C.-Y., Erhardt, A., & Kay, M. A. (2003). Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Molecular Therapy, 8, 495–500.
Chen, Z.-Y., Riu, E., He, C. Y., Xu, H., & Kay, M. A. (2008). Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Molecular Therapy, 16, 548–556.
Walther, W., Stein, U., Fichtner, I., Malcherek, L., Lemm, M., & Schlag, P. M. (2001). Non-viral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Therapy, 8, 173–180.
Walther, W., Siegel, R., Kobelt, D., Knösel, T., Dietel, M., Bembenek, A., et al. (2008). Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer. Clinical Cancer Research, 14, 7545–7553.
Walther, W., Stein, U., Voss, C., Schmidt, T., Schleef, M., & Schlag, P. M. (2003). Stability analysis for long-term storage of naked DNA: Impact on nonviral in vivo gene transfer. Analytical Biochemistry, 318, 230–235.
Acknowledgements
We thank U. Stein for helpful discussion and J. Conde Lopez for assistance with the figures. This work was supported by the H.W. & J. Hector foundation, grant M48.2 (to WW) as well as by the CliniGene Network of Excellence funded by the European Commission FP6 Research Program under contract LSHB-CT-2006-018933 and the German Federal Ministry of Education and Research (BMBF) by the grant BioChancePLUS (0313749) to PlasmidFactory.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kobelt, D., Schleef, M., Schmeer, M. et al. Performance of High Quality Minicircle DNA for In Vitro and In Vivo Gene Transfer. Mol Biotechnol 53, 80–89 (2013). https://doi.org/10.1007/s12033-012-9535-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-012-9535-6